Mereo BioPharma Group

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MREO and other ETFs, options, and stocks.

About MREO

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649).

CEO

Denise Vera Scots-Knight

CEODenise Vera Scots-Knight

Employees

Employees39

Headquarters

London, Greater London

HeadquartersLondon, Greater London

Founded

2015

Founded2015

Employees

Employees39

MREO Key Statistics

Market cap

42.62M

Market cap42.62M

Price-Earnings ratio

-1.05

Price-Earnings ratio-1.05

Dividend yield

—

Dividend yield—

Average volume

1.45M

Average volume1.45M

High today

$0.2859

High today$0.2859

Low today

$0.2616

Low today$0.2616

Open price

$0.2789

Open price$0.2789

Volume

504.82K

Volume504.82K

52 Week high

$3.05

52 Week high$3.05

52 Week low

$0.20

52 Week low$0.20

MREO News

Simply Wall St 4d

Here's Why We're Not Too Worried About Mereo BioPharma Group's Cash Burn Situation

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost mo...

Analyst ratings

71%

of 7 ratings

Buy

71.4%

Hold

28.6%

Sell

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.